Pictet Asset Management (Switzerland)’s Adaptive Biotechnologies ADPT Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$18.4M	Buy	2,741,086 +856,846	+45%	+$6.37M	0.02%	489
2023 Q1	$16.6M	Buy	1,884,240 +1,251,512	+198%	+$11M	0.02%	504
2022 Q4	$4.83M	Buy	632,728 +158,695	+33%	+$1.23M	0.01%	748
2022 Q3	$3.38M	Buy	474,033 +178,651	+60%	+$1.68M	0.01%	820
2022 Q2	$2.39M	Buy	295,382 +150,154	+103%	+$1.32M	﹤0.01%	916
2022 Q1	$2.02M	Hold	145,228	–	–	﹤0.01%	962
2021 Q4	$4.08M	Sell	145,228 -431,472	-75%	-$13.2M	﹤0.01%	881
2021 Q3	$19.6M	Buy	+576,700	New	+$20.9M	0.02%	518

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s ADPT Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Adaptive Biotechnologies (ADPT) stake by 45% in Q2 2023, buying an estimated $6.37M and bringing the position to 2,741,086 shares worth $18.4M. The position accounts for 0.02% of the portfolio, ranked #489.

Pictet Asset Management (Switzerland) first reported a position in ADPT in Q3 2021 and has held it in 8 quarters since. The position peaked at $19.6M in Q3 2021. 210 funds tracked by Wall St. Rank hold ADPT as of Q2 2023.

Pictet Asset Management (Switzerland) held 2,741,086 shares of Adaptive Biotechnologies worth $18.4M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 856,846 Adaptive Biotechnologies shares in Q2 2023, an estimated $6.37M.
Adaptive Biotechnologies made up 0.02% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #489 holding.
Pictet Asset Management (Switzerland) first reported a position in Adaptive Biotechnologies in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Adaptive Biotechnologies position peaked at $19.6M in Q3 2021.
210 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.